1. Home
  2. ILMN vs CPAY Comparison

ILMN vs CPAY Comparison

Compare ILMN & CPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • CPAY
  • Stock Information
  • Founded
  • ILMN 1998
  • CPAY 1986
  • Country
  • ILMN United States
  • CPAY United States
  • Employees
  • ILMN N/A
  • CPAY N/A
  • Industry
  • ILMN Medical Specialities
  • CPAY EDP Services
  • Sector
  • ILMN Health Care
  • CPAY Technology
  • Exchange
  • ILMN Nasdaq
  • CPAY Nasdaq
  • Market Cap
  • ILMN 23.6B
  • CPAY 24.1B
  • IPO Year
  • ILMN 2000
  • CPAY 2010
  • Fundamental
  • Price
  • ILMN $147.52
  • CPAY $364.48
  • Analyst Decision
  • ILMN Buy
  • CPAY Buy
  • Analyst Count
  • ILMN 19
  • CPAY 12
  • Target Price
  • ILMN $162.67
  • CPAY $379.00
  • AVG Volume (30 Days)
  • ILMN 2.1M
  • CPAY 437.4K
  • Earning Date
  • ILMN 02-06-2025
  • CPAY 02-05-2025
  • Dividend Yield
  • ILMN N/A
  • CPAY N/A
  • EPS Growth
  • ILMN N/A
  • CPAY 9.84
  • EPS
  • ILMN N/A
  • CPAY 14.01
  • Revenue
  • ILMN $4,390,000,000.00
  • CPAY $3,877,478,000.00
  • Revenue This Year
  • ILMN N/A
  • CPAY $8.44
  • Revenue Next Year
  • ILMN $4.28
  • CPAY $11.88
  • P/E Ratio
  • ILMN N/A
  • CPAY $25.49
  • Revenue Growth
  • ILMN N/A
  • CPAY 4.68
  • 52 Week Low
  • ILMN $97.36
  • CPAY $247.10
  • 52 Week High
  • ILMN $156.66
  • CPAY $385.30
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 55.71
  • CPAY 52.45
  • Support Level
  • ILMN $140.67
  • CPAY $356.09
  • Resistance Level
  • ILMN $151.75
  • CPAY $371.00
  • Average True Range (ATR)
  • ILMN 4.62
  • CPAY 6.11
  • MACD
  • ILMN 0.75
  • CPAY -2.98
  • Stochastic Oscillator
  • ILMN 71.27
  • CPAY 36.19

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About CPAY Corpay Inc.

Corpay Inc is a global S&P500 corporate payments company that helps businesses and consumers pay expenses in a simple, controlled manner. Its suite of modern payment solutions helps its customers better manage vehicle-related expenses (such as fueling and parking), travel expenses (e.g. hotel bookings), and payables (e.g. paying vendors). This results in its customers saving time and ultimately spending less.

Share on Social Networks: